Conflicts of Interest The authors declare no conflicts of interest. References 1, , , , and , “A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) Modulator Therapy,” Cureus Published online July 3, 13 (2021): 16144, https://doi.org/10.7759/cureus.16144. 2, , , et al., “Early Respiratory Infection Is Associated With Reduced Spirometry in Children With Cystic Fibrosis,” American Journal of Respiratory and Critical Care Medicine 190, no.